Suchergebnisse - "Mowry, Ellen M"

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria von Thompson, Alan J, Banwell, Brenda L, Barkhof, Frederik, Carroll, William M, Coetzee, Timothy, Comi, Giancarlo, Correale, Jorge, Fazekas, Franz, Filippi, Massimo, Freedman, Mark S, Fujihara, Kazuo, Galetta, Steven L, Hartung, Hans Peter, Kappos, Ludwig, Lublin, Fred D, Marrie, Ruth Ann, Miller, Aaron E, Miller, David H, Montalban, Xavier, Mowry, Ellen M, Sorensen, Per Soelberg, Tintoré, Mar, Traboulsee, Anthony L, Trojano, Maria, Uitdehaag, Bernard M J, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian G, Reingold, Stephen C, Cohen, Jeffrey A

“… The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. Scientific advances in the past 7 years …”
Volltext

Unsupervised MR harmonization by learning disentangled representations using information bottleneck theory von Zuo, Lianrui, Dewey, Blake E., Liu, Yihao, He, Yufan, Newsome, Scott D., Mowry, Ellen M., Resnick, Susan M., Prince, Jerry L., Carass, Aaron

“… •Unsupervised MR harmonization without traveling subjects.•Unified latent space for MR contrast synthesis.•A novel framework for disentangling contrast and …”
Volltext

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis von Sotirchos, Elias S, Bhargava, Pavan, Eckstein, Christopher, Van Haren, Keith, Baynes, Moira, Ntranos, Achilles, Gocke, Anne, Steinman, Lawrence, Mowry, Ellen M, Calabresi, Peter A

“… To study the safety profile and characterize the immunologic effects of high- vs low-dose cholecalciferol supplementation in patients with multiple sclerosis …”
Weitere Angaben

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators von Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.

“… Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in …”
Volltext

The influence of nutritional factors on the prognosis of multiple sclerosis von von Geldern, Gloria, Mowry, Ellen M.

“… In this Review, von Geldern and Mowry discuss the potential effects of vitamin D and other dietary components on the disease course of multiple sclerosis (MS) …”
Volltext

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy von Gadani, Sachin P., Reyes-Mantilla, Maria, Jank, Larissa, Harris, Samantha, Douglas, Morgan, Smith, Matthew D., Calabresi, Peter A., Mowry, Ellen M., Fitzgerald, Kathryn C., Bhargava, Pavan

“… Sphingosine-1-phosphate receptor (S1P) modulators and anti-CD20 therapies impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have …”
Volltext

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data von Goldman, Myla D, LaRocca, Nicholas G, Rudick, Richard A, Hudson, Lynn D, Chin, Peter S, Francis, Gordon S, Jacobs, Adam, Kapoor, Raj, Matthews, Paul M, Mowry, Ellen M, Balcer, Laura J, Panzara, Michael, Phillips, Glenn, Uitdehaag, Bernard M J, Cohen, Jeffrey A

“… We report analyses of a pooled database by the Multiple Sclerosis Outcome Assessments Consortium to evaluate 4 proposed components of a multidimensional test …”
Weitere Angaben

The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease von Mowry, Ellen M, Glenn, Justin D

“… Multiple sclerosis (MS) is a neuroinflammatory autoimmune disease of unknown etiology, although genetic components and environmental triggers are thought to …”
Weitere Angaben

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) von Mowry, Ellen M., Bermel, Robert A., Williams, James R., Benzinger, Tammie L. S., de Moor, Carl, Fisher, Elizabeth, Hersh, Carrie M., Hyland, Megan H., Izbudak, Izlem, Jones, Stephen E., Kieseier, Bernd C., Kitzler, Hagen H., Krupp, Lauren, Lui, Yvonne W., Montalban, Xavier, Naismith, Robert T., Nicholas, Jacqueline A., Pellegrini, Fabio, Rovira, Alex, Schulze, Maximilian, Tackenberg, Björn, Tintore, Mar, Tivarus, Madalina E., Ziemssen, Tjalf, Rudick, Richard A.

“… Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS) …”
Volltext

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis von Fitzgerald, Kathryn C., Bhargava, Pavan, Smith, Matthew D., Vizthum, Diane, Henry-Barron, Bobbie, Kornberg, Michael D., Cassard, Sandra D., Kapogiannis, Dimitrios, Sullivan, Patrick, Baer, David J., Calabresi, Peter A., Mowry, Ellen M.

“… Intermittent fasting or calorie restriction (CR) diets provide anti-inflammatory and neuroprotective advantages in models of multiple sclerosis (MS); data in …”
Volltext

Emerging Concepts on the Gut Microbiome and Multiple Sclerosis von Glenn, Justin D., Mowry, Ellen M.

“… Microbiota of the human body perform fundamental tasks that contribute to normal development, health, and homeostasis and are intimately associated with …”
Volltext

Intranasal insulin for improving cognitive function in multiple sclerosis von Newsome, Scott D., Fitzgerald, Kathryn C., Hughes, Abbey, Beier, Meghan, Koshorek, Jacqueline, Wang, Yujie, Maldonado, Daniela Pimentel, Shoemaker, Thomas, Malik, Taimur, Bayu, Tarik, Ravenna, Pablo E., Avornu, Ama, Sotirchos, Elias S., Romba, Meghan, Muschelli, John, Brown, Todd T., Calabresi, Peter A., Mowry, Ellen M.

“… Cognitive impairment is common in people with multiple sclerosis (PwMS). There is an urgent need to identify/develop novel therapies that can help cognitive …”
Volltext

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism von Fitzgerald, Kathryn C., Smith, Matthew D., Kim, Sol, Sotirchos, Elias S., Kornberg, Michael D., Douglas, Morgan, Nourbakhsh, Bardia, Graves, Jennifer, Rattan, Ramandeep, Poisson, Laila, Cerghet, Mirela, Mowry, Ellen M., Waubant, Emmanuelle, Giri, Shailendra, Calabresi, Peter A., Bhargava, Pavan

“… The circulating metabolome provides unique insights into multiple sclerosis (MS) pathophysiology, but existing studies are relatively small or characterized …”
Volltext

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis von Sotirchos, Elias S, Gonzalez-Caldito, Natalia, Dewey, Blake E, Fitzgerald, Kathryn C, Glaister, Jeffrey, Filippatou, Angeliki, Ogbuokiri, Esther, Feldman, Sydney, Kwakyi, Ohemaa, Risher, Hunter, Crainiceanu, Ciprian, Pham, Dzung L, Van Zijl, Peter C, Mowry, Ellen M, Reich, Daniel S, Prince, Jerry L, Calabresi, Peter A, Saidha, Shiv

“… The effects of disease-modifying therapies (DMTs) on region-specific brain atrophy in multiple sclerosis (MS) are unclear. To determine the effects of higher …”
Weitere Angaben

Associations of sNfL with clinico‐radiological measures in a large MS population von Sotirchos, Elias S., Fitzgerald, Kathryn C., Singh, Carol M., Smith, Matthew D., Reyes‐Mantilla, Maria, Hersh, Carrie M., Hyland, Megan H., Canissario, Ryan, Simmons, Sarah B., Arrambide, Georgina, Montalban, Xavier, Comabella, Manuel, Naismith, Robert T., Qiao, Min, Krupp, Lauren B., Nicholas, Jacqueline A., Akgün, Katja, Ziemssen, Tjalf, Rudick, Richard, Fisher, Elizabeth, Bermel, Robert A., Mowry, Ellen M., Calabresi, Peter A.

“… Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput assays on widely accessible platforms in large, real‐world MS …”
Volltext

Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery von Mowry, Ellen M., Carey, Robert F., Blasco, Maria R., Pelletier, Jean, Duquette, Pierre, Villoslada, Pablo, Malikova, Irina, Roger, Elaine, Kinkel, R. Phillip, McDonald, Jamie, Bacchetti, Peter, Waubant, Emmanuelle

“… Patients with early multiple sclerosis (MS) have stereotyped attack severity and recovery. We sought to determine if polymorphisms in MS susceptibility genes …”
Volltext

Retinal measurements predict 10‐year disability in multiple sclerosis von Rothman, Alissa, Murphy, Olwen C., Fitzgerald, Kathryn C., Button, Julia, Gordon‐Lipkin, Eliza, Ratchford, John N., Newsome, Scott D., Mowry, Ellen M., Sotirchos, Elias S., Syc‐Mazurek, Stephanie B., Nguyen, James, Caldito, Natalia Gonzalez, Balcer, Laura J., Frohman, Elliot M., Frohman, Teresa C., Reich, Daniel S., Crainiceanu, Ciprian, Saidha, Shiv, Calabresi, Peter A.

“… Objective Optical coherence tomography (OCT)‐derived measures of the retina correlate with disability and cortical gray matter atrophy in multiple sclerosis …”
Volltext

Genetic predictors of relapse rate in pediatric MS von Graves, Jennifer S, Barcellos, Lisa F, Shao, Xiaorong, Noble, Janelle, Mowry, Ellen M, Quach, Hong, Belman, Anita, Casper, T Charles, Krupp, Lauren B, Waubant, Emmanuelle

“… Genetic ancestry, sex, and individual alleles have been associated with multiple sclerosis (MS) susceptibility. To determine whether established risk factors …”
Weitere Angaben

Accelerometry-Assessed Physical Activity and Circadian Rhythm to Detect Clinical Disability Status in Multiple Sclerosis: Cross-Sectional Study von Bou Rjeily, Nicole, Sanjayan, Muraleetharan, Guha Niyogi, Pratim, Dewey, Blake E, Zambriczki Lee, Alexandra, Hulett, Christy, Dagher, Gabriella, Hu, Chen, Mazur, Rafal D, Kenney, Elena M, Brennan, Erin, DuVal, Anna, Calabresi, Peter A, Zipunnikov, Vadim, Fitzgerald, Kathryn C, Mowry, Ellen M

“… Tools for measuring clinical disability status in people with multiple sclerosis (MS) are limited. Accelerometry objectively assesses physical activity and …”
Volltext

Early Aggressive Treatment Approaches for Multiple Sclerosis von Simpson, Alexandra, Mowry, Ellen M., Newsome, Scott D.

“… Purpose of review This review presents a comprehensive analysis of the current high-efficacy disease-modifying therapies (DMTs) available for treatment of …”
Volltext